Iwashita M, Adachi T, Katayama E, Kudo Y, Takeda Y
Maternal and Perinatal Center, Tokyo Women's Medical College, Japan.
Horm Res. 1994;41 Suppl 1:22-8. doi: 10.1159/000183939.
The present study was undertaken to elucidate the physiological role and the regulation of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) in human luteinizing granulosa cells. IGFBP-1 abolished IGF-I-stimulated estradiol production by luteinizing granulosa cells in a dose-dependent manner with a 50% inhibitory concentration (IC50) of 0.27 nM. Similarly, IGFBP-1 inhibited 125I-IGF-I binding to granulosa cells. IGFBP-1 was identified by Western immunoblot and specific enzyme immunoassay in the granulosa-cell-conditioned medium after 24 h culture. Immunoreactive IGFBP-1 released into the medium was inhibited by both IGF-I and follicle-stimulating hormone dose-dependently with an IC50 of 0.14 and 0.13 nM, respectively, while human chorionic gonadotropin-stimulated IGFBP-1 release with a 50% effective dose (ED50) of 0.6 nM. These results suggest that IGFBP-1 is involved in follicular development and granulosa cell differentiation in the human ovary and that gonadotropins may influence IGF-I action by modifying IGFBP-1 levels within the ovary.
本研究旨在阐明胰岛素样生长因子(IGF)结合蛋白-1(IGFBP-1)在人黄素化颗粒细胞中的生理作用及调节机制。IGFBP-1以剂量依赖方式消除IGF-I刺激的黄素化颗粒细胞雌二醇生成,50%抑制浓度(IC50)为0.27 nM。同样,IGFBP-1抑制125I-IGF-I与颗粒细胞的结合。培养24小时后,通过蛋白质免疫印迹法和特异性酶免疫测定法在颗粒细胞条件培养基中鉴定出IGFBP-1。释放到培养基中的免疫反应性IGFBP-1分别被IGF-I和促卵泡激素以剂量依赖方式抑制,IC50分别为0.14和0.13 nM,而人绒毛膜促性腺激素以50%有效剂量(ED50)为0.6 nM刺激IGFBP-1释放。这些结果表明,IGFBP-1参与人卵巢卵泡发育和颗粒细胞分化,促性腺激素可能通过改变卵巢内IGFBP-1水平影响IGF-I的作用。